Development of a strategy for preclinical and clinical study of a new prolonged finished dosage form

Devel­op­ment of a strategy for preclin­ical and clinical study of a new prolonged finished dosage form

19 February 2021

CPD has developed a strategy for preclinical and clinical study of a new prolonged finished dosage form in order to further obtain a registration certificate.

Заявка успешно отправлена
В ближайшее время с вами свяжутся менеджеры для уточнения деталей